Literature DB >> 3541046

Senile dementia and Alzheimer's disease. Brain blood flow and metabolism.

S Hoyer.   

Abstract

Dementia of Alzheimer type is not form of accelerated aging. Blood flow, oxygen consumption and glucose utilization of the normally aged brain are maintained unchanged from the 3rd to the 7th decade of life. Thereafter, these parameters may decrease. Brain blood flow and oxidative metabolism is reduced in dementia of Alzheimer type and thus is different from the aged-matched mentally healthy subjects. There is evidence that the predominant impairment among these parameters may occur in cerebral glucose metabolism. This disturbance may precede changes in cerebral oxygen consumption and blood flow. Cerebral hypometabolism of glucose is accentuated in the temporo-parietal cortex. This finding may be helpful in diagnosing dementia of Alzheimer type.

Entities:  

Mesh:

Year:  1986        PMID: 3541046     DOI: 10.1016/0278-5846(86)90018-7

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  10 in total

1.  Glucose metabolism as the site of the primary abnormality in early-onset dementia of Alzheimer type?

Authors:  S Hoyer; K Oesterreich; O Wagner
Journal:  J Neurol       Date:  1988-01       Impact factor: 4.849

Review 2.  Alois Alzheimer revisited: differences in origin of the disease carrying his name.

Authors:  K Maurer; S Hoyer
Journal:  J Neural Transm (Vienna)       Date:  2006-10-23       Impact factor: 3.575

3.  Editorial: Siegfried Hoyer's concept of Alzheimer pathophysiology.

Authors:  Lutz Frölich; Walter E Müller; Peter Riederer
Journal:  J Neural Transm (Vienna)       Date:  2015-01-24       Impact factor: 3.575

Review 4.  Age-related changes in cerebral oxidative metabolism. Implications for drug therapy.

Authors:  S Hoyer
Journal:  Drugs Aging       Date:  1995-03       Impact factor: 3.923

5.  Univ.-Prof. Dr. med. Siegfried Hoyer 1933-2014.

Authors:  Peter Riederer
Journal:  J Neural Transm (Vienna)       Date:  2014-06       Impact factor: 3.575

6.  Effects of long-term treatment with pioglitazone on cognition and glucose metabolism of PS1-KI, 3xTg-AD, and wild-type mice.

Authors:  F Masciopinto; N Di Pietro; C Corona; M Bomba; C Pipino; M Curcio; A Di Castelnuovo; D Ciavardelli; E Silvestri; L M T Canzoniero; I Sekler; A Pandolfi; S L Sensi
Journal:  Cell Death Dis       Date:  2012-12-20       Impact factor: 8.469

Review 7.  Vegetables and Their Bioactive Compounds as Anti-Aging Drugs.

Authors:  Hamza Mechchate; Aicha El Allam; Nasreddine El Omari; Naoufal El Hachlafi; Mohammad Ali Shariati; Polrat Wilairatana; Mohammad S Mubarak; Abdelhakim Bouyahya
Journal:  Molecules       Date:  2022-04-02       Impact factor: 4.411

8.  Suppression of microRNA-9-5p rescues learning and memory in chronic cerebral hypoperfusion rats model.

Authors:  Na Wei; Kai Zheng; Rui Xue; Sheng-Li Ma; Hua-Yan Ren; Hui-Fen Huang; Wei-Wei Wang; Jing-Jing Xu; Kui-Sheng Chen
Journal:  Oncotarget       Date:  2017-11-11

Review 9.  Neurodegenerative Diseases: Regenerative Mechanisms and Novel Therapeutic Approaches.

Authors:  Rashad Hussain; Hira Zubair; Sarah Pursell; Muhammad Shahab
Journal:  Brain Sci       Date:  2018-09-15

Review 10.  The Erythrocytic Hypothesis of Brain Energy Crisis in Sporadic Alzheimer Disease: Possible Consequences and Supporting Evidence.

Authors:  Elena Kosenko; Lyudmila Tikhonova; Gubidat Alilova; Amparo Urios; Carmina Montoliu
Journal:  J Clin Med       Date:  2020-01-12       Impact factor: 4.241

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.